Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits

K Y Thong, R E J Ryder, M L Cull, C Walton, ABCD Nationwide Exenatide and Liraglutide Audit Contributors, Priya George

    Research output: Contribution to journalLetter

    4 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)690-692
    Number of pages3
    JournalDiabetic Medicine
    Volume29
    Issue number5
    DOIs
    Publication statusPublished - 2012

    Cite this